CCRM supports the development & commercialization of regenerative medicines & associated enabling technologies, with a specific focus on cell & gene therapy.
Ontario can boast exciting, innovative and transformational life sciences companies and organizations. Read @LifeSciencesON's Success Stories 2026. CCRM is pleased to be featured again this year. Find us on page 12 and check out #OmniaBio on page 38.
lifesciencesontario.ca/wp-co…
Cal Strode, a @Signalsblogs blogger himself, goes back to a post in 2016 to hold our bloggers accountable for predictions they made about the future of #iPSCs. How did they do? Read on.
Mark your calendar for IonQ's Q3 2026 earnings call on Thursday, November 5 at 4:30 pm ET.
Join us to hear Chairman & CEO @NiccoloDeMasi and COO & CFO Inder Singh as they share our financial results and business highlights.
Register for the earnings call → lnkd.in/eN-fTXQE#IonQ#QuantumIsNow#FutureOfQuantum
Dr. Jun Takahashi has received the 2026 Ogawa-Yamanaka Stem Cell Prize from @GladstoneInst for his pioneering work translating iPS cell biology into a therapy for Parkinson’s disease. bioengineer.org/takahashi-wi…
Hot off the press! 📢 Our Q3 2026 Gene, Cell and RNA Therapy Landscape Report, developed with Citeline, is here.
Explore seven new approvals, an expanding clinical pipeline and the latest advancements shaping the field.
Read more: bit.ly/4ufliLp#ASGCT#CGT
Led by Alex Marson, researchers from Gladstone and @StanfordMed used a technique known as perturb-seq to shed new light on how gene regulatory networks operate in human immune cells.
med.stanford.edu/news/insigh…
DEADLINE 📢
Canada Postdoctoral Research Award program application deadline is TODAY!
🗓️ October 19, before 8 pm ET.
Instructions ▶️ tinyurl.com/yxe4ajfe
ALT IMAGE: Background in shades of green to blue with undulating horizontal white lines in the center. Canada logo in white at the bottom right.
Dr. Patricia Beaston has joined Seraxis as Chief Medical Officer. As a former FDA officer, she had review responsibilities for islet cell transplantation. Pending approval of our proposed merger with Seraxis, she will be CMO of BetaNova.
Learn more: bit.ly/4zBqeNn
The 2027 #OBIO Investment Summit is an opportunity for VCs to network with one another, meet other venture-backed companies & best in class innovators, and make connections with Canada’s top research institutions.
Register now! 🔗obioinvestmentsummit.com/202…
Women are most commonly diagnosed with #dysautonomia. What is it & can #stemcells make a difference in treating the improper functioning of the autonomic nervous system? Ellie Kroeger explores the efficacy of treating it with MSCs signalsblog.ca/raising-aware…